FDA to recemmend remdesivir officially for coronavirus treatment

by Webscare Inc Webscare
On Wednesday, researches delivered a piece of good news about possible treatment of novel coronavirus by showing the satisfactory results of their experimental drug trials of remdesivir. According to them, the drug is beneficial in recovering the patients quickly from the disease. FDA, the US Food and Drug Administration didn’t approve any drug yet, officially for the treatment of COVID-19. But, it seems they are planning to approve an emergency-use of the drug remdesivir, says The New York Times.

While giving a statement to CNN, the FDA states that they are in constant talk with Gilead Sciences, the producer of the drug, about accelerating the availability of the medicine to patients. The FDA’s spokesman Michael Felberbaum said that as a part of the FDA’s commitment to increase accessibility as well as the production of the potential coronavirus treating drug, remdesivir. The US federal agency also let themselves in on the discussion with Gilead Sciences about producing remdesivir and its rapid availability to patients.

A research conducted by the US government-funded department revealed that COVID patients who are treated with remdesivir dose recovered so much fast as compared to those patients who didn’t take the drug. The US federal agency is trying to give a slight hope to the public in these deadly pandemic crises, which has affected more than 1 million people with the deaths of 61500 Americans. Therefore FDA will soon approve remdesivir as coronavirus treatment, officially. 

Furthermore, the head of NIAID (National Institute of Allergy and Infectious Diseases) gave positive signs about the results of the remdesivir experiment.

At the White House, in a meeting with a President, Doctor Anthony Fauci stated that stats suggest that remdesivir showed a remarkable, positive, and significant effect in reducing the recovery time from the deadly novel coronavirus. The results from initial drug trials express as fast as 11 to 15 days of recovery time for the virus patients.

Sponsor Ads

About Webscare Inc Junior   Webscare

2 connections, 0 recommendations, 14 honor points.
Joined APSense since, July 21st, 2019, From Sargodha, Pakistan.

Created on May 2nd 2020 08:26. Viewed 182 times.


No comment, be the first to comment.
Please sign in before you comment.